PROTALIX BIOTHERAPEUTICS INC - COM (PLX)

CUSIP: 74365A101

Q1 2015 13F Holders as of 31 Mar 2015

Type / Class
Equity / COM
Total 13F shares
28,846,836
Share change
-3,315,150
Total reported value
$51,533,750
Price per share
$1.78
Number of holders
35
Value change
-$6,098,203
Number of buys
7
Number of sells
22

Quarterly Holders Quick Answers

What is CUSIP 74365A101?
CUSIP 74365A101 identifies PLX - PROTALIX BIOTHERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PROTALIX BIOTHERAPEUTICS INC - COM (PLX) as of Q1 2015

As of 31 Mar 2015, PROTALIX BIOTHERAPEUTICS INC - COM (PLX) was held by 35 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 28,846,836 shares. The largest 10 holders included FEDERATED INVESTORS INC /PA/, BAILLIE GIFFORD & CO, Consonance Capital Management LP, BlackRock Advisors LLC, DAFNA Capital Management LLC, MENORA MIVTACHIM HOLDINGS LTD., Mivtachim The Workers Social Insurance Fund Ltd. (Under Special Management), CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM, BlackRock Group LTD, and BlackRock Inc.. This page lists 35 institutional shareholders reporting positions in this security for the Q1 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.